Los Angeles Capital Management & Equity Research Inc. increased its stake in Humana Inc. (NYSE:HUM) by 613.6% during the third quarter, according to its most recent filing with the SEC. The fund owned 26,340 shares of the insurance provider’s stock after buying an additional 22,649 shares during the quarter. Los Angeles Capital Management & Equity Research Inc.’s holdings in Humana were worth $6,417,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Reliance Trust Co. of Delaware boosted its holdings in shares of Humana by 0.7% in the 2nd quarter. Reliance Trust Co. of Delaware now owns 1,123 shares of the insurance provider’s stock worth $270,000 after buying an additional 8 shares during the last quarter. WFG Advisors LP boosted its holdings in shares of Humana by 4.5% in the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after buying an additional 20 shares during the last quarter. Cadence Capital Management LLC boosted its holdings in shares of Humana by 0.4% in the 2nd quarter. Cadence Capital Management LLC now owns 5,682 shares of the insurance provider’s stock worth $1,367,000 after buying an additional 22 shares during the last quarter. Financial Advisors Network Inc. boosted its holdings in shares of Humana by 3.4% in the 2nd quarter. Financial Advisors Network Inc. now owns 1,413 shares of the insurance provider’s stock worth $340,000 after buying an additional 46 shares during the last quarter. Finally, HL Financial Services LLC boosted its holdings in shares of Humana by 0.9% in the 2nd quarter. HL Financial Services LLC now owns 7,963 shares of the insurance provider’s stock worth $1,916,000 after buying an additional 68 shares during the last quarter. 96.70% of the stock is currently owned by institutional investors.

In related news, insider William Kevin Fleming sold 3,071 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total value of $770,759.58. Following the transaction, the insider now directly owns 7,681 shares in the company, valued at $1,927,777.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Timothy S. Huval sold 7,803 shares of the company’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $258.14, for a total transaction of $2,014,266.42. Following the completion of the transaction, the vice president now owns 8,831 shares in the company, valued at $2,279,634.34. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 20,660 shares of company stock worth $5,319,600. 0.80% of the stock is owned by company insiders.

Humana Inc. (HUM) opened at $233.46 on Monday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61. The firm has a market cap of $33,352.12, a P/E ratio of 19.92, a P/E/G ratio of 1.60 and a beta of 0.91. Humana Inc. has a 52-week low of $186.25 and a 52-week high of $264.56.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.27 by $0.12. The company had revenue of $13.28 billion for the quarter, compared to analysts’ expectations of $13.41 billion. Humana had a net margin of 3.49% and a return on equity of 15.99%. Humana’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the prior year, the business earned $3.18 earnings per share. analysts anticipate that Humana Inc. will post 11.63 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s dividend payout ratio (DPR) is 12.59%.

COPYRIGHT VIOLATION NOTICE: “Humana Inc. (HUM) Shares Bought by Los Angeles Capital Management & Equity Research Inc.” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/11/20/humana-inc-hum-shares-bought-by-los-angeles-capital-management-equity-research-inc.html.

HUM has been the topic of a number of research analyst reports. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $273.00 price target on the stock in a report on Tuesday, October 3rd. Deutsche Bank AG boosted their price target on shares of Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Jefferies Group LLC reissued a “hold” rating and issued a $257.00 price target on shares of Humana in a report on Friday, August 4th. Finally, BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a report on Wednesday, August 23rd. Thirteen investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $252.81.

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.